MedTrace Logo

Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

NCT03395574 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-12-24

No results posted yet for this study

Summary

in our study the investigators aim to assess the effect of terlipressin on cerebral oxygenation monitored by cerebral oxymetry and cerebral blood flow measured by transcranial doppler.

Conditions

  • Terlipressin Adverse Reaction
  • Liver Transplantation

Interventions

DRUG

Terlipressin

drug will be given after 30 minutes of induction of anesthesia

DRUG

Normal saline

drug will be given after 30 minutes as placebo in control group

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • ahmed mohamed mokhtar, M.D · kasralainy faculty of medicine, Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-25
Primary Completion
2018-11-25
Completion
2018-11-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03395574 on ClinicalTrials.gov